Session
Evolving the Pharmaceutical Industry and Improving Patient Safety with Blockchain
The pharmaceutical industry is central to global health and recovery. The FDA’s recent Drug Supply Chain Security Act (DSCSA) mandates the creation of an electronic, interoperable system to identify and trace prescription drugs in the U.S. Achieving DSCSA compliance will require cooperation from multiple members of today’s complex global supply chain – while the industry also grapples with the pressures of the coronavirus pandemic. Learn about the blockchain solution improving transparency and visibility into product location, movement, investigations of suspect products, recalls, and more – all key elements in blockchain’s potential to improve the safety of prescription drugs in the US.
